Reply
- PMID: 34600775
- DOI: 10.1016/j.ophtha.2021.08.019
Reply
Comment on
-
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1. Ophthalmology. 2021. PMID: 32882310 Clinical Trial.
-
Re: Jaffe et al.: C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration (Ophthalmology. 2021;128:576-586).Ophthalmology. 2021 Dec;128(12):e219. doi: 10.1016/j.ophtha.2021.08.018. Epub 2021 Sep 29. Ophthalmology. 2021. PMID: 34600774 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources